Meningitis News and Research

Latest Meningitis News and Research

Universal meningitis vaccination for college students may be too costly, study suggests

A computer-generated model developed by Johns Hopkins Medicine researchers adds to evidence that providing universal vaccination against meningitis B infection to students entering college may be too costly to justify the absolute number of cases it would prevent.

19 Dec 2018

Meningococcal bacteria with antibiotic resistance are at risk of increasing worldwide

In a new report published in Expert Review of Vaccines, the Global Meningococcal Initiative- a leading group of scientists, doctors and public health officials - warns that the incidence of meningococcal meningitis strains with resistance to traditional antibiotics is at risk of increasing worldwide.

19 Dec 2018

Researchers use new methods to optimize treatments for tuberculosis meningitis

Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain--or tuberculosis meningitis (TBM)--is often deadly, always hard to treat, and a particular threat to young children.

6 Dec 2018

Clearer diagnosis of polio-like illness in young children

Johns Hopkins researchers have analyzed patient data from 45 cases of what they thought was acute flaccid myelitis, the polio-like outbreak occurring in U.S. children, and realized that only 75 percent of diagnosed cases were AFM.

4 Dec 2018

New study launched in Burkina Faso to test typhoid conjugate vaccine

A new study has been launched in Burkina Faso for Bharat Biotech's typhoid conjugate vaccine. It is the second clinical study underway in Africa for the vaccine and the first in West Africa.

4 Dec 2018

Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows

The global disease burden of meningitis remains unacceptably high, and progress lags substantially behind that of other vaccine-preventable diseases, warns a new analysis published in The Lancet Neurology.

15 Nov 2018

Breakthrough research reveals how deadly pneumococcus avoids immune defenses

Scientists at the University of Liverpool have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design.

12 Nov 2018

Study shows how pneumococci challenge the immune system

Pneumococci are the most common cause of respiratory tract infections, such as otitis and sinusitis, as well as of severe infections like pneumonia and meningitis.

12 Nov 2018

Scientists move closer to gonorrhea vaccine after large-scale proteomic study

In a study of proteins historic in its scope, researchers at Oregon State University have pushed closer both to a vaccine for gonorrhea and toward understanding why the bacteria that cause the disease are so good at fending off antimicrobial drugs.

8 Nov 2018

Innovative computer software sheds new light on genetic processes underlying deadly diseases

Innovative computer software developed by University of Leicester scientists is shedding new light on the genetic makeup of deadly pathogens responsible for meningitis and gastroenteritis.

23 Oct 2018

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Polyganics today announced that it has initiated enrollment of patients into a first-in-human clinical trial of LIQOSEAL, its dura sealant patch.

23 Oct 2018

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda Pharmaceutical Company Limited today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients.

22 Oct 2018

Virginia Tech researcher receives $1.7 million to study herpes simplex virus

The National Institute of Neurological Disorders and Stroke of the National Institutes of Health has awarded Andrea Bertke, an assistant professor of infectious diseases in the Department of Population Health Sciences in the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, $1.7 million to study the neuron-specific regulation of herpes simplex viruses 1 and 2.

11 Oct 2018

Penn scientists to explore new approach for predicting and treating diseases at individual level

A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.

3 Oct 2018

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Fina Biosolutions announces that the United States Patent and Trademark Office has issued a patent for expression and purification of the conjugate vaccine protein CRM197 in E. coli.

27 Sep 2018

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.

24 Sep 2018

Most parents aren't able to recognize meningitis until it's too late

New research commissioned by GSK has shown that the majority of parents incorrectly think that a rash or stiff neck are the first signs of meningitis.

14 Sep 2018

UH researchers win $3.5 million grant to develop technology that combats multi-drug resistant bacteria

Two UH researchers have won a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases to develop technology that will quickly suggest the most promising combinations of antibiotics to kill certain resistant bacteria.

30 Aug 2018

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB

In one-fifth of people with active tuberculosis, the site of disease is outside the lungs. Some forms of extrapulmonary TB, such as TB meningitis, are extremely dangerous, where a rapid diagnosis can make all the difference to a patient.

28 Aug 2018

Scientists develop mathematical model to predict viral outbreaks in advance

Scientists have identified the cause of outbreaks of enterovirus, one of the most prevalent types of virus in the world.

24 Aug 2018

Meningitis News and Research

Latest Meningitis News and Research

Universal meningitis vaccination for college students may be too costly, study suggests

Meningococcal bacteria with antibiotic resistance are at risk of increasing worldwide

Researchers use new methods to optimize treatments for tuberculosis meningitis

Clearer diagnosis of polio-like illness in young children

New study launched in Burkina Faso to test typhoid conjugate vaccine

Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows

Breakthrough research reveals how deadly pneumococcus avoids immune defenses

Study shows how pneumococci challenge the immune system

Scientists move closer to gonorrhea vaccine after large-scale proteomic study

Innovative computer software sheds new light on genetic processes underlying deadly diseases

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Virginia Tech researcher receives $1.7 million to study herpes simplex virus

Penn scientists to explore new approach for predicting and treating diseases at individual level

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Most parents aren't able to recognize meningitis until it's too late

UH researchers win $3.5 million grant to develop technology that combats multi-drug resistant bacteria

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB

Scientists develop mathematical model to predict viral outbreaks in advance

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Meningitis News and Research

Latest Meningitis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in